Viruses. Monkey SA7 adenovirus, C8 strain, was isolated from a rectal smear of a Cercopithecus aethiops monkey, and was kindly supplied to us by H. Malherbe. Oncogenic properties of this virus have been described (7; Altstein et al., in press). The virus stock used was the 12th passage of this strain in GMK cells.
. The growth medium consisted of Hanks solution with 0.5% lactalbumin hydrolysate and 5% bovine serum. After infection, the cultures were maintained in medium 199 without serum.
Viruses. Monkey SA7 adenovirus, C8 strain, was isolated from a rectal smear of a Cercopithecus aethiops monkey, and was kindly supplied to us by H. Malherbe. Oncogenic properties of this virus have been described (7; Altstein et al., in press). The virus stock used was the 12th passage of this strain in GMK cells.
The prototype strains of human adenoviruses, types 1, 2, 3, 5, and 7, were received from the Moscow Institute for Viral Preparations, and were grown in HEK cells. Virus stocks were maintained at -20 C. None of the strains studied induced synthesis of immunofluorescent stainable SV40 T antigen in GMK cells, and none contained infectious SV40 virus.
Immune sera. Neutralizing antisera were prepared in rabbits. Antisera to the T antigen of the C8 virus were obtained from hamsters bearing transplanted and primary tumors induced by this virus. Two pools of these sera were used. Both of them reacted specifically in the complement fixation (CF) test with a tumor antigen from transplanted C8 tumors and did not react with extracts of hamster tumors induced by monkey adenoviruses SA7 (BI05), SA7 (C626) (Altstein et al., in press), or SV40, or with adenovirus group CF antigen or the C8 viral antigen.
Virus assays. The viruses were titrated by the plaque or end point dilution methods, by using GMK cells for C8 adenovirus and HEK cells for human adenoviruses. Both types of cells were used for titration of the hybrid virus. In titrations by the end point dilution method, four test-tube tissue cultures were used for each 10-fold dilution of the virus; virus dilutions were made in medium 199. Final results of titrations were registered at 3 weeks.
Plaque titrations were done in 50-ml flasks (square surface about 20 cm2) with rubber stoppers. Adsorption of virus (0.2 ml/flask) was carried out for 1 hr at 37 C. The agar overlay consisted of 1.5% agar (Difco) in Earle's solution with 10% boiled skimmed milk, 0.4% sodium bicarbonate, 1%, bovine serum, 0.0017% neutral red, penicillin (100 units/ml), and streptomycin (100 units/ml). Final results of titrations were obtained 14 to 18 days after infection.
Neutralization test. Neutralization was carried out by mixing 0.9 ml of a virus-containing material with 0.1 ml of immune serum, followed by incubation for 2 hr at 37 C. In quantitative neutralization tests, 10-fold dilutions of the virus were mixed with a constant dilution of the serum. Plaque-forming activity of the Ad2C8 virus.
During the study of plaque-forming activity of the Ad2C8, C8, and Ad2 viruses, the following results were obtained: (i) Ad2C8 preparations induced plaque formation in both GMK and HEK cells (the titer of virus in HEK cells being 2 to 3 logio higher than that in GMK cells); (ii) the C8 virus induced plaque formation only in GMK cells; (iii) the Ad2 virus induced plaque formation only in HEK cells. There was no marked difference in the time of appearance and size of the plaques induced by Ad2C8 and Ad2 in HEK cells. In GMK cells, plaques induced by the Ad2C8 appeared at the same time as the C8 plaques, that is, 8 to 9 days after infection.
Plaque-forming activity of Ad2C8 was neutralized by anti-Ad2 but not by anti-C8 serum, both in GMK and in HEK cells ( Table 1) . Addition of anti-C8 serum to the agar overlay also failed to inhibit plaque formation by Ad2C8 virus. Figure 1 presents some examples of the doseresponse relationships for plaque-forming activity of the Ad2C8 virus in GMK and HEK cells. When GMK cells were used, the dose-response curve was of two-hit character; in HEK cells, it was one-hit. The dose-response curves for plaqueforming activity of C8 virus in GMK cells and of the Ad2 virus in HEK cells were of one-hit character. These data indicate that two types of virus particles are present in the Ad2C8 preparation, and the interaction of both particles is necessary for plaque formation.
Plaque-forming activity of the Ad2C8 virus in GMK cells was enhanced by simultaneous infection with human adenoviruses. A constant dose of human adenovirus (Adl, Ad2, Ad3, Ad5, Ad7) was inoculated into the GMK flask cultures (multiplicity of infection, 0.1 to 3 TCID5o/cell) simultaneously with dilutions of Ad2C8. Cultures inoculated only with the Ad2C8 virus or only Table 4 presents data on the Ad2C8 clones from the plaques formed in GMK cells in the presence of added human adenovirus. The clones were neutralized only by the serum homologous to the adenovirus used as helper.
Induction of the C8 T antigen by Ad2C8. Ad2C8 infection of GMK cells induced the T antigen typical of the C8 virus, and T antigen-inducing activity of the Ad2C8 was neutralized by antiAd2 but not by anti-C8 serum (Table 5) . T antigen-inducing activity of the C8 virus was neutralized by anti-C8 but not by anti-Ad2 serum. The Ad2 virus alone did not induce T antigen reactive with C8 hamster serum.
None of the tested antigens reacted in CF tests with the antiserum against SV40 T antigen, and immunofluorescence tests of GMK cells infected with the Ad2C8, C8, or Ad2 viruses and fixed (6, 10, 12) . In our experiments, it was demonstrated that joint infection of GMK cells with human and monkey adenoviruses leads to the formation of hybrids which possess some properties of the original viruses. The hybrid virus preparation induced plaques in GMK cells analogous to those of the C8 virus; in contrast to the latter, the hybrid was neutralized by antiAd2 serum. Examination of Ad2C8 preparations by electron microscopy showed typical adenovirus particles; adeno-associated virus particles were not detected (unpublished data).
In the study of plaque-forming activity of the Defective particles of Ad-SV40 are a result of recombination of genetic material of the adenovirus and SV40 (2, 14) . The origin of the second type of defective particles (MAC), which appeared during passage of the adeno-virus type 7 in monkey kidney cells, is unknown. Ad2C8 particles appeared under conditions of joint replication of adenoviruses of human and monkey origin, and apparently contain the genetic material of the monkey adenovirus. Study of the mechanism of formation of "adeno-adeno" hybrids is in progress.
